PegBio Co., Ltd. — Capital/Financing Update 2018

Aug 10, 2018

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [218 x 43] intentionally omitted <==

CMBC CAPITAL HOLDINGS LIMITED

(Incorporated in Bermuda with limited liability)

(Stock Code: 1141)

VOLUNTARY ANNOUNCEMENT FINANCIAL ASSISTANCE FROM CONTROLLING SHAREHOLDER

Reference is made to the announcements of CMBC Capital Holdings Limited (the “ Company ”, together with its subsidiaries, the “ Group ”) dated 23 July 2017, 27 December 2017 and 2 May 2018 concerning the provision of financial assistance by its controlling shareholder (the “ Announcements ”). Unless otherwise defined, capitalised terms used in this announcement have the same meanings as defined in the Announcements.

The Board is pleased to announce that on 2 August 2018, the Company entered into Supplemental Agreement (the “ Supplemental Agreement ”) with CMBCI, pursuant to which CMBCI has agreed to: (1) extend the availability period of the Facility by twelve (12) months to two years after the date of first drawdown of the Facilities; and (2) increase the maximum principal amount of the Facilities by HK$1,000,000,000 to HK$8,000,000,000. According to the Supplemental Agreement, the interest rate of the Facilities has been adjusted as follows: (1) from the date of first drawdown to 30 September 2018 (both days inclusive), 4% per annum; and (2) from 1 October 2018 to the expiry of the Availability Period (both days inclusive), at the interest rate to be agreed by the parties hereto at the beginning of each calendar quarter with reference to the applicable HIBOR/LIBOR rate plus a reasonable margin, which in turn will be determined with reference to, among others, the prevailing market interest rate and the funding cost of CMBCI, but in no event higher than 4.5% per annum.

The Group intends to utilise the Facilities for the purposes of, inter alia , developing its securities investment and provision of finance businesses.

– 1 –

CMBCI is a company incorporated in Hong Kong with limited liability. It is a controlling shareholder (as defined in the Listing Rules) of the Company and a connected person (as defined in the Listing Rules) of the Company. As such, the transaction contemplated under the Supplemental Agreement constitutes a connected transaction of the Company under Chapter 14A of the Listing Rules. Since the Supplemental Agreement has been entered into after arm’s length negotiation between the Company and CMBCI and determined on normal commercial terms or better and the Agreement is not secured by any asset or guarantee of the Group, the Supplemental Agreement and the transaction contemplated thereunder is fully exempted from shareholders’ approval, annual review and all disclosure requirements under Rule 14A.90 of the Listing Rules.

By order of the Board CMBC Capital Holdings Limited Li Jinze Chairman

Hong Kong, 10 August 2018

As at the date of this announcement, the executive Directors are Mr. Li Jinze, Mr. Ding Zhisuo and Mr. Ng Hoi Kam, the non-executive Directors are Mr. Ren Hailong and Mr. Liao Zhaohui, and the independent non-executive Directors are Mr. Lee, Cheuk Yin Dannis, Mr. Wu Bin and Mr. Wang Lihua.

– 2 –